Nutex Health Inc.
NUTX
$122.90
$4.443.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4,120.33% | 295.13% | -58.56% | 89.54% | 92.93% |
| Total Depreciation and Amortization | 21.64% | 12.77% | 4.77% | 8.72% | 4.82% |
| Total Amortization of Deferred Charges | -30.68% | 667.78% | -24.45% | -77.39% | 5,347.76% |
| Total Other Non-Cash Items | 2,336.57% | 34.71% | 1,401.29% | 477.84% | -311.45% |
| Change in Net Operating Assets | -2,006.28% | -1,728.96% | -152.00% | 1,408.83% | -41.46% |
| Cash from Operations | 1,570.44% | 103.01% | 244.94% | 107,704.88% | 190.02% |
| Capital Expenditure | 91.27% | -147.86% | 78.54% | 81.82% | 83.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 91.27% | -145.66% | 92.62% | 58.65% | 86.47% |
| Total Debt Issued | 37.94% | -71.89% | 141.81% | -81.13% | -61.65% |
| Total Debt Repaid | 41.71% | 20.90% | 18.54% | 71.26% | -89.14% |
| Issuance of Common Stock | -- | -- | -- | -51.59% | 32,767.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1,430.98% | -- | -- | -- | 68.71% |
| Other Financing Activities | -- | -216.12% | -9.00% | 30.70% | -- |
| Cash from Financing | -219.80% | 23.71% | 90.16% | -139.96% | 93.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 450.84% | 31.02% | 202.93% | 13,240.63% | 664.18% |